INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
https://doi.org/10.14412/1996-7012-2010-589
Abstract
The paper provides evidence for the clinical efficacy of infliximab, its effect on the extra-articular manifestations of rheumatoid arthritis-vasculitis,
rheumatoid nodules, and cardiovascular pathology. It discusses reasons for the lower effect of therapy and the possibilities of its correction,
by increasing the dose of the agent or reducing an infusion interval.
rheumatoid nodules, and cardiovascular pathology. It discusses reasons for the lower effect of therapy and the possibilities of its correction,
by increasing the dose of the agent or reducing an infusion interval.
References
1.
Review
For citations:
Balabanova RM, Balabanova RM. INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS? Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2010;4(1):61-65. (In Russ.) https://doi.org/10.14412/1996-7012-2010-589
Views:
1353
Email this article 